GLP-1 therapies continue to reshape chronic disease treatment, triggering regulatory updates, new clinical findings and intensifying competition across the pharmaceutical market. On Jan. 13, the FDA ...

Should you microdose GLP-1 drugs? Here’s what experts say - One in seven people using GLP-1s are microdosing the medication including celebrities like Andy Cohen and Brooks Nader ...

Scientists have discovered natural GLP-1 in joint fluid, which could open up a new treatment option for arthritis.

The health of state employees and MassHealth members “is on the line,” clinicians and patients warned on Tuesday, due to diminishing coverage for GLP-1 drugs for weight loss. The cries come against a ...

New research suggests GLP-1 drugs may improve liver and heart health even without major weight loss, reshaping how doctors ...

GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand their ...

Telehealth company eMed has partnered with CVS Caremark to offer a GLP-1 benefit model that lets employers subsidize weight loss medications without covering the full cost, Axios reported Feb. 16. The ...

INDIANAPOLIS — It’s just days before Christmas as medical workers wheel 7-year-old Jessa Milender through the halls of the hospital. The normally bubbly child is limp, face-down on a medical gurney.

GLP-1s are driving demand for smaller portions, due to reducing consumer appetites. Could this lead to smaller pack sizes?

The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. Healthcare companies have ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...